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Dyskerin is Required for Tumor Cell Growth Through Mechanisms that are
Independent of its Role in Telomerase and Only Partially Related to its Function in
Precursor rRNA Processing
Abstract
Dyskerin is an essential nucleolar protein required for the biogenesis of ribonucleoproteins that
incorporate H/ACA RNAs. Through binding to specific H/ACA RNAs, dyskerin exerts most of its influence
in the cell. To that end, dyskerin is a core component of the telomerase complex and is required for
normal telomere maintenance. Dyskerin is also required for post-transcriptional processing of precursor
rRNA. Germline dyskerin mutations increase cancer susceptibility. Conversely, wild-type dyskerin is
usually overexpressed and not mutated in sporadic cancers. However, the contributions of dyskerin to
sporadic tumorigenesis are unknown. Described herein, we demonstrate that acute loss of dyskerin
function by RNA interference significantly reduced steady-state levels of H/ACA RNAs, disrupted the
morphology and inhibited anchorage-independent growth of telomerase-positive and telomerase-negative
human cell lines. Unexpectedly, dyskerin depletion only transiently delayed rRNA maturation but with no
appreciable effect on the levels of total 18S or 28S rRNA. Instead, while rRNA processing defects typically
trigger p53-dependent G1 arrest, dyskerin-depleted cells accumulated in G2/M by a p53-independent
mechanism, and this was associated with an accumulation of aberrant mitotic figures that were
characterized by multi-polar spindles. Telomerase activity and the rate of rRNA processing are typically
increased during neoplasia. However, our cumulative findings indicate that dyskerin contributes to tumor
cell growth through mechanisms which do not require the presence of cellular telomerase activity, and
which may be only partially dependent upon the protein’s role in rRNA processing. These data also
reinforce the notion that loss and gain of dyskerin function may play important roles in tumorigenesis.
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Dyskerin is required for tumor cell growth through mechanisms
that are independent of its role in telomerase and only partially
related to its function in precursor rRNA processing
Faizan Alawi* and Ping Lin
Department of Pathology, School of Dental Medicine, University of Pennsylvania, Philadelphia,
PA, USA.

Abstract
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Dyskerin is an essential nucleolar protein required for the biogenesis of ribonucleoproteins that
incorporate H/ACA RNAs. Through binding to specific H/ACA RNAs, dyskerin exerts most of its
influence in the cell. To that end, dyskerin is a core component of the telomerase complex and is
required for normal telomere maintenance. Dyskerin is also required for post-transcriptional
processing of precursor rRNA. Germline dyskerin mutations increase cancer susceptibility.
Conversely, wild-type dyskerin is usually overexpressed and not mutated in sporadic cancers.
However, the contributions of dyskerin to sporadic tumorigenesis are unknown. Described herein,
we demonstrate that acute loss of dyskerin function by RNA interference significantly reduced
steady-state levels of H/ACA RNAs, disrupted the morphology and inhibited anchorageindependent growth of telomerase-positive and telomerase-negative human cell lines.
Unexpectedly, dyskerin depletion only transiently delayed rRNA maturation but with no
appreciable effect on the levels of total 18S or 28S rRNA. Instead, while rRNA processing defects
typically trigger p53-dependent G1 arrest, dyskerin-depleted cells accumulated in G2/M by a p53independent mechanism, and this was associated with an accumulation of aberrant mitotic figures
that were characterized by multi-polar spindles. Telomerase activity and the rate of rRNA
processing are typically increased during neoplasia. However, our cumulative findings indicate
that dyskerin contributes to tumor cell growth through mechanisms which do not require the
presence of cellular telomerase activity, and which may be only partially dependent upon the
protein’s role in rRNA processing. These data also reinforce the notion that loss and gain of
dyskerin function may play important roles in tumorigenesis.
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BACKGROUND
Dyskerin is a highly conserved and vital nucleolar protein [1–3]. Together with several other
factors, dyskerin is required for the biosynthesis of ribonucleoproteins (RNPs) that
incorporate H/ACA RNAs [4,5]. These functional, non-coding RNAs (ncRNAs) are
characterized by a 5’-hairpin-hinge-hairpin-tail-3’ secondary structure (H) with the
nucleotides A-C-A located three positions from the 3’ end. There are at least 100 known
human H/ACA RNAs, including telomerase RNA (TERC) and subsets of small nucleolar
*
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RNAs (snoRNAs) and Cajal body RNAs [5,6]. However, only one H/ACA RNA is
incorporated into each RNP and dyskerin binds to and stabilizes the RNA molecules
throughout the course and completion of RNP maturation. The protein components of
functionally mature H/ACA RNPs include dyskerin complexed with three other highly
conserved proteins - NHP2, NOP10 and GAR1 [5].
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Dyskerin is thought to exert most of its influence in the cell via H/ACA RNA binding.
Through binding to TERC, dyskerin is needed for normal function of the telomerase RNP
and for telomere maintenance [6]. In contrast, a majority of H/ACA snoRNAs participate in
post-transcriptional processing of nascent ribosomal RNA (rRNA) [2,3,7]. Most act as
guides in the pseudouridination of precursor rRNA, and dyskerin catalyzes the isomerization
of specific uridine residues to pseudouridines. Similarly, through direct interaction with H/
ACA Cajal body RNAs, dyskerin participates in pseudouridination of spliceosomal RNA
[5]. In addition, a number of H/ACA RNAs have do not have any known pseudouridination
targets or function [5]. Thus, at least some H/ACA RNAs, and by extension, dyskerinassociated H/ACA RNPs may regulate other cellular processes beyond those that the protein
is typically associated with. Indeed, recent reports suggest a role for dyskerin in the
translational control of specific mRNAs [8–11], maintenance of telomere integrity
independently of telomere length regulation [12], and in regulation of a subset of
microRNAs [13,14]. It is not known if these latter functions are entirely dependent upon
dyskerin-H/ACA RNA interactions. Nonetheless, dyskerin appears to regulate a diverse
array of important cellular functions.
Germline dyskerin mutations are associated with the X-linked variant of dyskeratosis
congenita [1]. Actively proliferating cells and tissues that undergo rapid turnover are most
severely affected in these individuals. This results in a wide-ranging phenotype that affects
primarily the lymphoid, hematologic, epithelial and bone tissue compartments.
Mucocutaneous manifestations, aplastic anemia, pulmonary fibrosis and osteoporosis are
among the most characteristic clinical findings [1]. There is also a significantly increased
risk for the development of cancer; carcinomas of the head and neck, skin and
gastrointestinal tract, lymphomas and leukemias are the most common [15]. Recent reports
have begun to provide clarity into the molecular mechanisms by which loss of dyskerin
function might contribute to neoplasia [9–11]. In contrast, an emerging body of evidence
suggests that gain of dyskerin function may be relevant in the pathogenesis of sporadic
cancers.
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We have previously shown that human dyskerin expression strongly correlates with active
cell proliferation [16]. Dyskerin expression is also upregulated under experimental
conditions that promote cell growth and proliferation, including via oncogenic stimulation
[17]. To that end, wild-type dyskerin is overexpressed and not mutated in a variety of cancer
types relative to patient-matched controls and high levels have been associated with cancer
progression and poor prognosis [18–24]. However, the mechanisms by which wild-type
dyskerin contributes to sporadic tumorigenesis remain obscure.
Telomerase activity is upregulated in the vast majority of human cancers [25]. This is
primarily a result of increased expression of telomerase reverse transcriptase (TERT), which
is the catalytic component of the telomerase complex [25]. However, we recently
demonstrated that dyskerin levels do not correlate with TERT expression and are not
dependent upon the presence of cellular telomerase activity in either human cell lines or in
cancer tissues [16]. In the current report, we further these findings to show that not only is
dyskerin required for the in vitro growth of telomerase-positive and telomerase-negative
transformed cell lines, but also that the repertoire of cellular functions that may be
influenced by dyskerin continues to expand.
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METHODS
Cell culture
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U2OS human osteosarcoma cells and HeLa cervical carcinoma cells were obtained from
American Type Culture Collection (Manassas, VA). The oral squamous cell carcinoma cell
line, UM-SCC-1 was a gift of Dr. Thomas Carey (University of Michigan). All cell lines
were grown in D-MEM containing high glucose (4,500 µg/mL), 1 mmol/L of glutamine,
10% fetal bovine serum, with 100 IU/mL penicillin and 100 IU/mL streptomycin.
siRNA transfections
siGENOME SMARTPool siRNA duplexes targeting DKC1 and GAPDH, and a negative
control, Non-Targeting siRNA pool #1 were from Dharmacon (Lafayette, CO). To validate
the effects of the DKC1 siRNA, we repeated most experiments using a custom-designed
anti-DKC1 siGENOME SMARTPool targeting the 3’-untranslated region. Transfections
were performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA), as per the
manufacturer’s protocol. All transfections were performed at least in triplicate, and every
experiment was performed two or more times.
Western blot analysis
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Whole cell lysates were extracted as described previously [17]. Antibodies against dyskerin,
β-actin, GAPDH, fibrillarin, nucleophosmin, p53, and secondary antibodies were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA). All Western blot analyses were
performed at least in duplicate.
Cell proliferation, cell cycle distribution, and anchorage-independent growth assays
An equal number of siRNA-transfected cells were seeded in 96-well plates and cell
proliferation was measured using the Cell Proliferation Reagent WST-1 (Roche Applied
Science, Indianapolis, IN), as previously described [16]. For cell cycle distribution analysis,
cells were fixed with cold 80% ethanol, resuspended in PBS, and stained with 10 µg/ml
propidium iodide containing 1 mg/ml RNase A (Sigma-Aldrich). Analyses were performed
on a Becton-Dickinson FacstarPLUS flow cytometer (BD Biosciences, San Jose, CA).
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To measure growth in soft agar, transfections were performed in triplicate with siCTRL or
siDyskerin, respectively, and then harvested 24 hrs later. After counting, 6000 cells from
each transfection well were suspended in 0.3% low-melting point agarose (Invitrogen)
diluted in D-MEM. One third of the suspension was then laid over a bed of 0.6% agarose/DMEM in each of three wells of a 6-well culture plate. The cells were allowed to grow for 5
days, after which they were analyzed by phase contrast microscopy using an Olympus IX50S8F inverted microscope. All images were obtained using SPOTsoftware Version 4.6
(Diagnostic Instruments, Inc., Sterling Heights, MI).
SnoRNA extraction and analysis
Total RNA was isolated using the miRNeasy kit (Qiagen, Valencia, CA) and then enriched
for small RNAs (< 200 nucleotides) using the RNeasy MinElute Cleanup kit (Qiagen). The
miScript PCR system (Qiagen) was used for quantitative RT-PCR analysis on a 7500 Real
Time PCR System (Applied Biosystems, Carlsbad, California). Pre-designed primers for
SNORA66, SNORA73A, SNORA74A, SNORD13, SNORD25, SNORD43, RNU5,
RNU6B, and miR-let-7g were obtained from Qiagen. Custom designed primers were used
for SNORA34, SNORA36B and SNORA81. These include: SNORA34_F
“CAGAGGCCTAAAGGACTGTC”, SNORA34_R
“AATGAAATAGCCATTCCCTACTGA”, SNORA81_F
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“TGCAGACACTAGGACCATGT”, SNORA81_R
“CACCCCAGTCTTTACAATCTAGTG”, SNORA36B_F
“TGTTAAGTTCAGTTCAGGGTAGC”, and SNORA36B_R
“TTCTATCCAATCATTTTCCCTAGC”. For quantitation, relative levels of these ncRNAs
were normalized to RNU6B. The expression of this latter RNA remained stable under our
experimental conditions.
Metabolic labeling of rRNA
SiRNA-treated cells were grown for thirty minutes in methionine-free DMEM (Invitrogen)
containing dialyzed fetal bovine serum (Invitrogen). L-[methyl-3H]-methionine (PerkinElmer, Waltham, MA) was then added to a final concentration of 50 µCi/mL. After thirty
minutes, the cells were washed with PBS and then incubated for up to two hours in complete
medium containing an excess of non-radioactive methionine. After agarose gel
electrophoresis using the Northern Max-Gly kit (Ambion, Austin, TX), the gels were
transferred to GeneScreen Plus Hybridization Transfer membranes (Perkin-Elmer), dried
and then analyzed by autoradiography using Biomax MS film and Biomax TranScreen LE
(Kodak, Rochester, NY). These latter exposures were performed at −80°C for at least three
days.
Immunofluorescent labeling of mitotic cells
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Asynchronous HeLa cells were cultured in 4-well Lab Tek chamber slides (Thermo
Scientific, Rochester, NY) and transfected with siDyskerin or siCTRL in three of the four
wells. Seventy-two hours later, the cells were fixed in 4% paraformaldehyde for 15 min at
37°C. After rinses with PBS and PBS-0.1% Tween-20 (PBST), the cells were blocked and
permeabilized with 0.2% bovine serum albumin and 0.1% Triton X-100 in PBS for 60 min.
Cells were incubated with anti-α-tubulin (1:100; Santa Cruz) for three hours at room
temperature, and then with a Cy-3 labeled secondary antibody (Jackson ImmunoResearch
Laboratories, West Grove, PA). DAPI (4,6-diamidino-2-phenylindole) was used to stain the
DNA. Coverslips were mounted onto the slides using GelMount (Biomeda Corporation,
Foster City, CA) and allowed to dry overnight prior to viewing. Cells were analyzed using a
Nikon Eclipse ES400 fluorescence microscope equipped with an Olympus DP70 Digital
Camera System and associated imaging software (Optical Apparatus, Ardmore, PA). All
images were processed with Adobe Photoshop CS (Abobe Systems, San Jose, CA) using the
“auto-contrast” functions.

RESULTS
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Dyskerin depletion perturbs cell cycle progression and proliferation
We began our studies by examining the effects of dyskerin depletion on the proliferation of
telomerase-positive UM-SCC1 oral squamous cell carcinoma cells and HeLa cervical
carcinoma cells, and telomerase-negative U2OS osteosarcoma cells. U2OS cells do not
express either TERC or TERT; telomere maintenance occurs through homologous DNA
recombination [26].
The cells were transiently transfected with siRNAs targeting DKC1 (siDyskerin), GAPDH
(siGAPDH) or a non-specific control (siCTRL). After 48 hours, dyskerin expression was
markedly and specifically reduced in all cell lines relative to the controls (Figure 1A and
Supp. Fig. S1). In parallel, flow cytometric analysis revealed a small but significant
accumulation of siDyskerin cells in G2/M (≈3.5% – 9%, depending on the experiment and
cell line used) relative to the siCTRL and siGAPDH cells (Figure 1B and Supp. Fig. S1).
This was reproducible in several repetitions of our experiments. Similar findings were also
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seen using a custom-designed siRNA reagent that targeted the 3’-untranslated region of
DKC1 (not shown).

NIH-PA Author Manuscript

There was no effect on cell proliferation after 72 hours of dyskerin depletion. However, after
six days of persistent dyskerin knockdown in U2OS cells, there was a small by significant
decrease in proliferation (p < 0.01; Figures 1C and 6A). This was associated with a 50%
reduction in the number of siDyskerin cells relative to siCTRL cells (Figure 1D). However,
unexpectedly, at this time, there was still only a mild disruption in the cell cycle profile of
the siDyskerin cells (Figure 1E). In contrast, even with prolonged dyskerin depletion, there
was no effect on the proliferation of UM-SCC1 or HeLa cells (not shown).
Dyskerin is required for anchorage-independent growth of tumor cells
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The effects of gene manipulation in monolayer cell cultures do not always parallel those
observed when cells are grown in the absence of a solid surface to which they could adhere.
Thus, we next tested the effects of dyskerin depletion on anchorage-independent growth.
U2OS and HeLa cells were transfected with the dyskerin and CTRL siRNAs. Twenty-four
hours later, the cells were plated in soft agar, and allowed to grow for for at least 5 days
before microscopic analysis. As expected, U2OS and HeLa siCTRL cells readily
proliferated in the agarose (Figure 2A). In contrast, the siDyskerin U2OS and HeLa cells
showed very poor anchorage-independent growth. Few siDyskerin cells were identified, and
where there were cells clustered together, the colonies were small. Anchorage-independent
growth is an in vitro hallmark of most transformed cells and strongly correlates with
tumorigenic growth potential in vivo [27]. Thus, downregulation of dyskerin inhibited the
tumorigenicity of telomerase-positive and telomerase-negative cells.
Loss of dyskerin disrupts cellular morphology
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As shown in Figure 2A, dyskerin knockdown resulted in unusual morphologic changes
whereby a number of the cells exhibited thin, markedly elongated cellular processes.
Knockdown of dyskerin also elicited similar morphologic changes in siDyskerin U2OS cells
(but not UM-SCC1 or HeLa cells) that were grown in monolayer (Figure 2B). To confirm
that the unusual morphology was a specific consequence of dyskerin knockdown, we
repeated the U2OS siRNA transfections, except this time we used the siRNA that targeted
the 3’-untranslated region of DKC1. On the 4th day after initial transfection, the cells were
transfected with pcDNA3-Flag-Dyskerin or the vector alone. Twenty-four hours later, the
cells were either harvested for protein or passaged, and then grown for an additional 24 hrs
before fixation and microscopic analysis. As expected, re-introduction of dyskerin restored
the proliferation and morphology of the siDyskerin cells (Figure 2C, D). Flag-dyskerin had
no observable effect on the siCTRL and siGAPDH cells, and the vector only control did not
reverse the effects of dyskerin depletion. This indicated that the observed effects were a
specific consequence of reduced dyskerin function.
Dyskerin regulates steady-state levels of H/ACA snoRNAs
To investigate the mechanisms by which dyskerin contributed to tumor cell growth, we first
tested the effects of dyskerin depletion on H/ACA RNAs. Within 48 hours after siRNA
transfection, loss of dyskerin led to a significant and specific reduction in the levels of six
randomly selected H/ACA snoRNAs. Although levels of these RNAs were variably
affected, in almost all cases, the expression of each was reduced by 2- to 4-fold relative to
the controls; this was independent of the cell line tested (Figure 3A, B). In contrast, levels of
all non-H/ACA RNAs remained essentially unchanged; these ncRNAs are not bound or
regulated by dyskerin [5,14]. We note that TERC expression was also reduced almost 2-fold
in the telomerase-positive cells (Figure 3B). TERC is not expressed in U2OS cells [26] and
hence was undetectable in these cells. Northern blot analysis was then used to validate a
Mol Carcinog. Author manuscript; available in PMC 2012 May 1.
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subset of the qRT-PCR results. As expected, levels of SNORA36B and SNORA81 were
markedly decreased after dyskerin depletion, while levels of non-HACA RNAs were
unaffected (Supp. Fig. S2).
Dyskerin is required for pseudouridination of small nuclear spliceosomal RNAs [5]. Yet, in
our experiments, the levels of RNU5A, RNU6B and RNU6 (see Supp. Fig. S2) were
remarkably constant; RNU6B was thus used as a quantitative control for normalization. This
suggests that loss of dyskerin function may not affect the steady-state levels of spliceosomal
RNA. This reinforces the findings of a recent report which showed that loss of murine
dyskerin also did not affect the levels of spliceosomal RNA [7].
Dyskerin depletion only transiently disrupts rRNA maturation in U2OS cells
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The majority of H/ACA snoRNAs are needed for precursor rRNA processing, and
pseudouridination is required for normal rRNA maturation [5]. Except for SNORA73A,
each of the other H/ACA snoRNAs described above has a known uridine target in 45S
precursor rRNA, with the subsequent pseudouridine incorporated into either mature 18S or
28S rRNA. Yet, surprisingly, after 6 days of persistent dyskerin depletion, there was no
appreciable effect on the relative abundances of mature 28S and 18S rRNA before and after
dyskerin depletion, or between the siDyskerin and siCTRL cells (Figure 4A). However, a
pulse-chase rRNA labeling experiment did reveal a disruption in precursor rRNA processing
in the siDyskerin U2OS cells, and to a lesser extent in UM-SCC1 cells (Figure 4B and Supp.
Figure S3). In U2OS siCTRL cells labeled with L-[methyl-3H]-methionine, levels of the 45S
rRNA precursor were significantly decreased over the duration of the experiment. This was
associated with a concomitant accumulation of newly synthesized 28S rRNA, thereby
indicative of appropriate processing. In contrast, between 30–60 minutes after the chase,
persistence of the large 45S rRNA precursor was clearly evident in the siDyskerin cells.
After 30 minutes, relative levels of 45S rRNA (normalized to 5S rRNA) were 1.3–1.5 fold
higher in the siDyskerin cells relative to amount of 45S rRNA in the siCTRL cells (Figure
4C). By 60 minutes, relative levels of 45S rRNA were 1.7–2 fold higher compared to the
control. Concomitantly, after the first 30 minutes in the siDyskerin cells, levels of newly
formed 28S rRNA were reduced 40–60% (depending on the siRNA used) relative to the
siCTRL cells, and by 15–35% after 60 minutes (Figure 4D). Yet, after 120 minutes,
processing of 45S rRNA and levels of 28S and 18S rRNA appeared equivalent in the
siCTRL and siDyskerin cells. Similar findings were observed in three independent
experiments. Thus, loss of dyskerin transiently perturbed rRNA processing in U2OS cells,
but not to an extent that there was an appreciable effect on the levels of total mature rRNA.
Atypical multi-polar mitoses are increased following dyskerin depletion
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Telomerase activity peaks during S phase and is repressed during G1 and G2/M [28]. In
mammalian cells, the bulk of rRNA processing occurs during G1 and S phases, diminishes
during G2 and completely ceases early in mitosis, only to be restored upon mitotic exit [29].
In light of our findings and the fact that dyskerin is a nucleolar protein, our observation that
loss of dyskerin delayed transit through G2/M arrest could not be readily explained.
However, emerging evidence suggests that dyskerin may also be an evolutionarily
conserved component of the mitotic spindle [30–34]. Moreover, we have observed at least
partial co-localization of human dyskerin with α-tubulin during metaphase and anaphase,
respectively; α-tubulin is a core component of the mitotic spindle (P. Lin, F. Alawi, in
preparation). Dyskerin was recently identified within purified HeLa cell mitotic spindle
extracts [30,31]. To that end, dyskerin depletion in these cells led to a small but remarkably
consistent and highly significant increase (≈7%; p = 0.0001) in the proportion of multi-polar
mitotic figures relative to the siCTRL cells (Figure 5A, B). Most were tri-polar, however
quadri-, penta- and even rare hexa-polar spindles were identified. There were no significant
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differences between the siCTRL and mock-transfected cells. This novel finding indicates a
possible rationale for the observed increase in G2/M cells following dyskerin knockdown,
and importantly, suggests a new addition to the repertoire of cellular functions that may be
influenced by this multi-functional protein.
Loss of dyskerin elicits growth arrest independently of p53
Human cells that harbor dyskerin mutations proliferate poorly in vitro and show a high rate
of apoptosis [6,35,36]. However, the decrease in proliferation of siDyskerin U2OS cells did
not result from activation of the apoptosis signaling cascade (not shown). Similarly, there
was no objective evidence of cellular senescence, as determined by a lack of senescenceassociated β-galactosidase staining (not shown). These observations are similar to those
described by Sieron et al [21] who reported that dyskerin depletion reduced the proliferation
of prostate cancer cells without eliciting either apoptosis or senescence.
At least one murine dyskerin-mutant has been shown to impair cell proliferation via a p53dependent mechanism [12]. Defects in telomere maintenance, impaired rRNA processing
and disruptions in normal mitosis are all known triggers of p53 [9,12,37]. U2OS cells
express wild-type p53 [38] while the protein is inactivated in HeLa [39] and mutated in UMSCC1 cells [40]. However, dyskerin depletion did not lead to upregulation of either p53
mRNA or protein in U2OS cells (Figure 6A, B).
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Activation of p53 may also occur through phosphorylation; serine 15 is phosphorylated
following DNA damage [12]. However, a p53 antibody that specifically recognizes
phosphorylated serine 15 did not identify any reactivity in the siDyskerin lysates (not
shown). We cannot exclude the possibility that p53 activation may have occurred through
phosphorylation at other residues. Yet, we note that loss of dyskerin also had no effect on
the expression of p53 transcriptional targets, including p21Waf/Cip1 and p27Kip1 (Figure 6B);
these latter factors are also implicated in cell cycle control [10,11]. Thus, the exact
mechanisms by which loss of dyskerin reduced cell proliferation remain unclear.

DISCUSSION
Several lines of evidence indicate that wild-type dyskerin may be important in the
pathogenesis of sporadic cancer [17–22]. Conversely, germline dyskerin mutations increase
cancer susceptibility [2,9,10,15]. Emerging evidence suggests that the mechanisms by which
loss of dyskerin contributes to tumorigenesis may not be related to the role of the protein in
either telomerase or in rRNA processing [9–11]. Our cumulative findings suggest wild-type
dyskerin may also contribute to tumor cell growth via alternative mechanisms.
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Murine dyskerin is required for cell proliferation via a mechanism that is dependent upon its
interaction with a functional telomerase complex [12]. In the absence of either Terc or Tert,
dyskerin-mutant primary murine cells proliferate at the same rate as dyskerin-wild-type
cells. However, we recently demonstrated that dyskerin levels do not correlate with TERT
expression or telomerase activity in either human cell lines or in cancer tissues [16]. Sieron
et al [21] recently showed that loss of dyskerin function impaired the proliferation of
telomerase-positive human prostate cancer cells. We now show that loss of dyskerin
function can also limit the proliferation of telomerase-negative cells; U2OS cells do not
express either TERT or TERC [26]. We have also shown for the first time that dyskerin is
required for anchorage-independent growth of telomerase-negative and telomerase-positive
cells. Thus, while dyskerin is a core component of the telomerase complex [6], our findings
strengthen the notion that wild-type dyskerin plays an important role in human tumor cell
growth and that this function is not dependent upon the presence of cellular telomerase
activity.
Mol Carcinog. Author manuscript; available in PMC 2012 May 1.
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Sieron et al [21] also reported unusual morphologic changes similar to the ones we observed
after dyskerin depletion. Although it wasn’t directly investigated, the authors theorized that
the anti-proliferative and morphologic effects of dyskerin knockdown were likely related to
a defect in protein synthesis resulting from diminished rRNA processing. However, our
findings suggest that the role of dyskerin in tumor cell growth may be only partially related
to its function in rRNA processing.
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Despite a significant and persistent decrease in H/ACA snoRNA expression, there was only
a transient delay in the maturation of newly synthesized rRNA following dyskerin depletion.
Due to an increased metabolic demand, the rate of rRNA processing is necessarily amplified
in tumor cells [41]. Thus, we cannot exclude the possibility that even a transient disruption
in rRNA maturation may be sufficient to slow the growth of tumor cells. Moreover, since
rRNAs are incorporated into ribosomes, it is possible that an abnormality in ribosome
function resulting from improperly modified rRNAs could adversely affect protein synthesis
and impair cell proliferation. Yet, while targeted dyskerin depletion disrupts rRNA
pseudouridination in human breast cancer cells [42], Montanaro et al [11] recently
demonstrated that there is no effect on global protein synthesis. During the course of our
studies, Gu et al [43] demonstrated that while the relative abundances of 18S and 28S
rRNAs are not diminished in dyskerin-mutant human cells relative to wild-type cells, the
mature rRNAs do exhibit a subtle shift in electrophoretic mobility under very specific
experimental conditions. Therefore, we cannot completely exclude the possibility that
dyskerin depletion may have had an aberrant effect on rRNA maturation, albeit undetectable
under our own experimental conditions. However, defects in rRNA processing typically
trigger p53-dependent G1 arrest [37]. In contrast, the dyskerin-depleted cells consistently
accumulated in G2/M. At least one mutant form of murine dyskerin triggers p53 activation;
rRNA processing and cell proliferation are impaired in these cells [7]. Yet, loss of dyskerin
function either through mutation or depletion may actually lead to a reduction in p53 protein
expression [9,11]. In our experiments, loss of dyskerin function in U2OS cells had no effect
on expression of either p53 mRNA or protein or its direct transcriptional targets. Taken
together, this suggests that the role of dyskerin in sporadic tumorigenesis is not dependent
on the presence of p53 and may not be entirely dependent on its role in rRNA processing.
The factors that link dyskerin to cell cycle regulation remain poorly defined and will require
elucidation.
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We note that in murine cells, germline dyskerin mutations do not significantly delay G2/M
progression [7,9]. This discrepancy could be a result of differences in cell type or in the
experimental conditions, or even due to possible functional differences between murine and
human dyskerin. However, if similarly small cell cycle differences were evident in dyskerinmutant cells, their significance may have been overlooked.
In an attempt to rationalize the G2/M accumulation, our experiments have led to discovery
of a possible novel role for dyskerin in mitosis. During mitosis, nucleolar disintegration is
accompanied by relocation of several rRNA processing factors to the perichromosal region
and the mitotic spindle [30,31,44]. In addition to playing key roles in precursor rRNA
processing, at least some of these factors are required for normal mitotic spindle formation.
Recent high-throughput, mass spectrometry-based studies identified human dyskerin and its
Drosophila and Xenopus orthologs contained within purified mitotic spindle extracts derived
from cells of each of the respective species [30–33]. In addition, yeast dyskerin was
originally characterized as a microtubule binding protein [34]. We have now demonstrated
for the first time that loss of dyskerin led to the accumulation of atypical mitoses with multipolar spindles. Future studies will be needed to determine the mechanisms by which
dyskerin contributes to mitotic spindle integrity. Whether or not this function is dependent
upon dyskerin-H/ACA RNA interactions will also require more detailed investigation.
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Nonetheless, our findings suggest that the repertoire of cellular processes that may be
influenced by dyskerin continues to expand.
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How loss and gain of dyskerin function may be associated with tumorigenesis
It is intriguing to speculate about the mechanisms by which loss and gain of dyskerin
function may contribute to tumorigenesis. Normal mitotic spindle assembly and function are
essential for the preservation of genomic integrity [22]. To that end, loss- and gain-offunction of various mitotic spindle proteins may play a role in cancer development and/or
progression [22,30,31]. Intriguingly, DKC1 was identified as one of only seventy genes that,
collectively, constitute a gene expression profile that strongly correlates with the
development of aneuploidy and is associated with poor clinical prognosis in a variety of
human cancers [22]. A majority of the genes identified in this molecular signature are
known to play important roles in mitotic spindle assembly, chromosome segregation and/or
cytokinesis. We note that transient overexpression of dyskerin had no appreciable effect on
wild-type U2OS, UM-SCC1 or HeLa cells, and we have not been able to obtain stable
dyskerin-expressing transfectants (not shown). Nonetheless, it is highly intriguing to
speculate that an alteration of physiologic dyskerin function, irrespective of the mechanism,
may perturb mitosis and contribute to tumorigenesis. This will require more detailed
investigation.
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In addition to the effects on H/ACA snoRNAs, we recently demonstrated that loss of
dyskerin function leads to a reduction in the levels of a subset of miRNAs that are encoded
within H/ACA snoRNAs [13]. MiRNAs are a class of ncRNAs that directly regulate posttranscriptional gene expression [14]. At least some miRNAs have oncogenic potential while
others have been ascribed tumor suppressive functions [45]. To our knowledge, the miRNAs
that are regulated by dyskerin have not yet been functionally validated. Nonetheless, it is
conceivable that dysregulation of miRNA-mediated translational control, either through
supraphysiologic or diminished dyskerin function could potentially impact an array of
factors that may be important for cancer development and/or progression [13]. This will also
need further study.
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Finally, we previously showed that dyskerin is a direct transcriptional target of the c-MYC
oncoprotein [17]. c-MYC is a transcription factor implicated in the pathogenesis of several
cancers; high c-MYC levels are often associated with poor prognosis [17,46]. The specific
contributions of dyskerin to c-MYC-mediated tumorigenesis are not known. However,
recent findings indicate that other protein components of mature H/ACA RNPs, including
NHP2 and GAR1, are also transcriptionally regulated by c-MYC [47,48]. The status of
GAR1 in neoplasia is unknown. However, like dyskerin, NHP2 expression is significantly
upregulated in sporadic cancers and high levels may be associated with poor clinical
prognosis [46,48]. Conversely, germline NHP2 and NOP10 mutations give rise to autosomal
recessive forms of dyskeratosis congenita, and cancer susceptibility is also a feature of these
genetic forms of the disease [15,49,50].
Pathogenic mutations in dyskerin, NHP2 and NOP10 impair the assembly of H/ACA RNPs
[4,51]. Alternatively, it has been suggested that high levels of dyskerin may also disrupt the
biogenesis of H/ACA RNPs [35]. To that end, loss- and gain-of-function of the precursor H/
ACA RNP assembly factor, SHQ1, impairs H/ACA RNP maturation [52]. Since the
functions of several H/ACA RNAs have not yet been identified [5], it is possible that
disruption of H/ACA RNP biogenesis by any mechanism may affect an array of important
cellular processes, and could potentiate cancer development and/or progression. Hence, the
findings from our current study may open up new and novel avenues of investigation into
the mechanisms by which dyskerin and H/ACA RNPs contribute not only to sporadic
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tumorigenesis, but also in the pathogenesis and phenotype of X-linked dyskeratosis
congenita.
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Figure 1. Loss of dyskerin function reduces the proliferation of telomerase-negative U2OS cells

A, U2OS cells were transiently transfected with siRNA directed against dyskerin
(siDyskerin) or GAPDH (siGAPDH). A non-target control (siCTRL) was used as a negative
control. By 3 days after initial transfection, dyskerin expression was reduced by more than
80% relative to the controls, while GAPDH expression was essentially undetectable. There
was no effect on the expression of other rRNA processing factors, including fibrillarin and
nucleophosmin. Similar results were obtained using a coding region siRNA (siDyskerin#1;
shown here) and a custom-designed DKC1 siGENOME SMARTPool (siDyskerin #2; not
shown). A western blot demonstrating dyskerin depletion after transfection with siDyskerin
#2 is shown in Fig. 6A. B, Cells were labeled with propridium iodide and analyzed by flow
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cytometry. There was a significant increase in the proportion of dyskerin-depleted cells in
G2/M (p <0.025). C, U2OS cells showed a significant reduction (p < 0.01) in their
proliferation after six days of persistent dyskerin depletion, irrespective of the siRNA used.
Relative cell proliferation was measured using the WST-1 colorimetric assay. D, Total
number of viable siDyskerin cells was reduced by almost 50% relative to the siCTRL cells.
There was no difference in the number of dead cells between the two conditions (not
shown). E, After six days of persistent dyskerin depletion, flow cytometric analysis revealed
only a small but highly significant increase in the proportion of siDyskerin cells in G2/M.
Only the siDyskerin #2 results are shown here. Error bars denote the standard deviations
derived from parallel transfections performed in triplicate wells. The experiments were
conducted twice for the cell proliferation assays and three times for the cell cycle analyses.
One representative experiment is shown here.
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Figure 2. Suppression of dyskerin function inhibits anchorage-independent growth and alters
cell morphology

A, U2OS and HeLa cells were transfected and 24 hours later, seeded into soft agar. After 5
days of growth, the cells were analyzed by phase contrast microscopy. While the siCTRL
cells readily grew under these conditions, siDyskerin cells proliferated very poorly in the
absence of a solid matrix. Bars = 300 µM. B, U2OS cells were transfected with siDyskerin
#1. After the 5th day, cells were harvested and re-seeded into 100 cm2 culture dishes.
Twenty-four hours later they were fixed and analyzed. Loss of dyskerin resulted in fewer
adherent cells relative to the controls and, of the cells that remained, several showed thin,
elongated cytoplasmic processes (arrows). A representative focus from each panel is
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enlarged to show detail. C, Cells were transfected with the siRNA targeting the 3’untranslated region of DKC1 (siDyskerin #2). On the 4th day, the cells were transfected with
pcDNA3-Flag-dyskerin. Immunoblotting with anti-dyskerin antibody showed expression of
the exogenous Flag-dyskerin transgene while endogenous dyskerin was effectively depleted.
As a negative control, the cells were also transfected with pcDNA3 only (not shown).
Transfections were performed in duplicate with similar results. D, In the absence of
dyskerin, the cells exhibited abnormal morphology (arrows). In contrast, restoration of
dyskerin function increased the number and restored the morphology of U2OS cells that
were depleted of the endogenous protein. A representative focus from the siDyskerin panel
is enlarged to show detail. Bars = 100 µM.
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Figure 3. Loss of dyskerin selectively reduces the accumulation of H/ACA RNAs

A, U2OS and B, UM-SCC1 cells were harvested on the 3rd day after siRNA transfection.
Total RNA was extracted and then enriched into one fraction containing small RNA (<200
nucleotides) and another containing large RNA. There was a greater than 2-fold decrease in
the expression of H/ACA snoRNAs, relative to the siCTRL and siGAPDH controls,
following dyskerin depletion in both cell lines. In contrast, there was essentially no effect on
the accumulation of other small RNAs that are not known to be bound to or stabilized by
dyskerin. B, TERC expression was also reduced by more than 2-fold in UM-SCC1 cells. As
expected, TERC expression was not detectable in U2OS cells. Except for TERC (*), the
levels of each transcript was measured relative to that of RNU6B, and then normalized to
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the ratio of the respective transcripts in the wild-type, untreated cells. We note that similar
results were obtained when transcript levels were normalized to RNU5A expression (not
shown). *Since TERC is 451 nucleotides in length, this transcript was enriched in the large
RNA fraction. Thus, for TERC analysis, quantitation was performed relative to β-actin
expression. The solid bars represent the mean values derived from qRT-PCR analyses of
triplicate transfections conducted in one representative experiment; error bars denote
standard deviations. The experiment was repeated twice with similar results.
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Figure 4. Dyskerin depletion transiently impairs precursor rRNA processing

U2OS cells were transfected with the appropriate siRNAs and analyzed six days later. A,
There was no appreciable effect on the amounts of either mature 18S or 28S rRNA
following dyskerin depletion. The gel was stained with ethidium bromide and the bands
were visualized on an Image Station 4000 (Kodak, Rochester, NY). B, The cells were
metabolically labeled with L-[methyl-3H]-methionine as described in Methods and
Materials. After 30 minutes, the 45S rRNA precursor persisted in the siDyskerin cells
relative to the siCTRL cells. This was associated with a decrease in the amount of newly
synthesized 28S rRNA. Following 60 minutes, persistence of 45S rRNA is clearly evident in
the siDyskerin cells, while differences in the levels of 28S rRNA are not as dramatic. By
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120 minutes, the rate of rRNA processing was essentially the same in the siCTRL and
siDyskerin cells. Similar results were observed with both dyskerin siRNAs. The bottom
panel shows the same blot exposed for nine days. C, Relative quantitation of 45S rRNA
normalized to 5S rRNA over the duration of the pulse-chase experiment. The values at the
60 minute time point (**) are shown in the right panel. D, Quantitation of 28S rRNA
normalized to the levels of 5S rRNA. The relative accumulation of 28S rRNA at the 30
minute timepoint (**) is shown on the right. All quantitations were performed using NIH
Image J. One representative experiment is shown.
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Figure 5. Loss of dyskerin leads to the accumulation of multi-polar mitotic spindles
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HeLa cells were cultured in 4-well chamber slides and transfected with siDyskerin or
siCTRL in three of the four wells. Seventy-two hours later, the cells were fixed, and then
immunolabeled with α-tubulin and DAPI. The experiments were then repeated to yield six
unique sets of dyskerin-depleted immunolabeled cells, six sets of siCTRL cells, and four sets
of mock-transfected HeLa cells. At least 350 consecutive mitoses (metaphase and anaphase
only) were then counted from each of the wells, and the number of atypical mitoses was
measured as a percentage of the total number of metaphase and anaphase cells counted. A,
Representative field demonstrating three mitotic figures with multi-polar spindles in the
siDyskerin cells (arrows). Six normal-appearing mitoses are seen in the siCTRL panel. Bar =
100 µM. B, For illustrative purposes: (a) normal bi-polar spindle (metaphase), (b) tri-polar
(metaphase), (c) tri-polar (anaphase), (d) quadri-polar (metaphase), and (e) hexa-polar
(metaphase). Overall, more than 19% of siDyskerin metaphases and/or anaphase cells
exhibited multi-polar spindles. In contrast, only 12–13% of the siCTRL and mocktransfected mitoses, respectively, were atypical; p = 0.0001. The solid bars represent the
average number of atypical mitoses calculated for each group; error bars denote standard
deviations.
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Figure 6. Downregulation of dyskerin has no effect on p53 expression

A, Dyskerin expression remained low for at least 6 days following siRNA transfection.
However, p53 levels remained constant for the duration of the experiment. There was also
no effect on other rRNA processing factors, including fibrillarin and nucleophosmin. B,
There was no change in mRNA expression of p53 or of its transcriptional targets p21 or p27.
Quantitation was performed relative to β-actin expression. The solid bars represent the mean
values derived from qRT-PCR analyses of triplicate transfections conducted in one
representative experiment; error bars denote standard deviations. The experiment was
repeated three times with similar results.
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